BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Edeline J, Raoul JL, Vauleon E, Guillygomac’h A, Boudjema K, Boucher E. Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study. World J Gastroenterol 2009; 15(6): 713-716 [PMID: 19222095 DOI: 10.3748/wjg.15.713]
URL: https://www.wjgnet.com/1948-5182/full/v15/i6/713.htm
Number Citing Articles
1
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology 2012; 56(4): 908 doi: 10.1016/j.jhep.2011.12.001
2
Govindarajan Narayanan, Yilun Koethe, Nicole Gentile. Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future AvenuesMedicina 2024; 60(2): 251 doi: 10.3390/medicina60020251
3
GEN-SHEN ZHONG, MIN-NA WU, XIAO-FANG GUO, SHENG-HUA ZHANG, QING-FANG MIAO, YONG-SU ZHEN. Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinasesOncology Reports 2012; 28(4): 1193 doi: 10.3892/or.2012.1910
4
Omar Abdel-Rahman. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedsideJournal of the Egyptian National Cancer Institute 2013; 25(4): 165 doi: 10.1016/j.jnci.2013.08.002
5
B. Alkofer, V. Lepennec, L. Chiche. Hepatocellular cancer in the non-cirrhotic liverJournal of Visceral Surgery 2011; 148(1): 3 doi: 10.1016/j.jviscsurg.2010.12.012
6
B. Alkofer, V. Lepennec, L. Chiche. Hépatocarcinome sur foie non cirrhotiqueJournal de Chirurgie Viscérale 2011; 148(1): 3 doi: 10.1016/j.jchirv.2010.12.015
7
Qiaomiao Lu, Yu Long, Yongkang Gai, Qingyao Liu, Dawei Jiang, Xiaoli Lan. [177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapyEuropean Journal of Nuclear Medicine and Molecular Imaging 2023; 50(8): 2342 doi: 10.1007/s00259-023-06155-x
8
Aly M. Azmy, Khalid E. Nasr, Nagy S. Gobran, M. Yassin. Gemcitabine Plus Carboplatin in Patients with Advanced Hepatocellular Carcinoma: Results of a Phase II StudyISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/420931
9
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain. EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology 2018; 69(1): 182 doi: 10.1016/j.jhep.2018.03.019
10
Franco Trevisani, Marta Frigerio, Valentina Santi, Alice Grignaschi, Mauro Bernardi. Hepatocellular carcinoma in non-cirrhotic liver: A reappraisalDigestive and Liver Disease 2010; 42(5): 341 doi: 10.1016/j.dld.2009.09.002
11
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCCMetabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
12
Brian A. Boone, David L. Bartlett, Amer H. Zureikat. Isolated Hepatic Perfusion for the Treatment of Liver MetastasesCurrent Problems in Cancer 2012; 36(2): 27 doi: 10.1016/j.currproblcancer.2011.12.001
13
Lorenza Rimassa, Armando Santoro. The present and the future landscape of treatment of advanced hepatocellular carcinomaDigestive and Liver Disease 2010; 42: S273 doi: 10.1016/S1590-8658(10)60516-6
14
Jinming Zhang, Yifeng Zheng, Xi Xie, Lan Wang, Ziren Su, Yitao Wang, Kam W. Leong, Meiwan Chen. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma EfficacyMolecular Pharmaceutics 2017; 14(11): 3644 doi: 10.1021/acs.molpharmaceut.7b00404
15
Hiroki Nishikawa, Toru Kimura, Ryuichi Kita, Yukio Osaki. Radiofrequency ablation for hepatocellular carcinomaInternational Journal of Hyperthermia 2013; 29(6): 558 doi: 10.3109/02656736.2013.821528
16
Conventional Oral Systemic Chemotherapy for Postoperative Hepatocellular CarcinomaJournal of Cancer Research Updates 2014; 3(1): 11 doi: 10.6000/1929-2279.2014.03.01.2
17
Vladimir M. Subbotin. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targetsDrug Discovery Today 2018; 23(3): 548 doi: 10.1016/j.drudis.2018.01.020
18
Aldo Parodi Pita. Factores epidemiológicos relacionados al Carcinoma Hepatocelular.Oncología (Ecuador) 2017; : 115 doi: 10.33821/195
19
JIANHONG ZHONG, BANGDE XIANG, LIANG MA, LEQUN LI. Conventional oral systemic chemotherapy for postoperative hepatocellular carcinoma: A systematic reviewMolecular and Clinical Oncology 2014; 2(6): 1091 doi: 10.3892/mco.2014.337
20
AntineoplasticsReactions Weekly 2021; 1849(1): 54 doi: 10.1007/s40278-021-93438-5
21
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in JapanCancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
22
Qin Liu, Rutian Li, Zhenshu Zhu, Xiaoping Qian, Wenxian Guan, Lixia Yu, Mi Yang, Xiqun Jiang, Baorui Liu. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticlesInternational Journal of Pharmaceutics 2012; 430(1-2): 350 doi: 10.1016/j.ijpharm.2012.04.008
23
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
24
Marcus A. Wörns, Timon Bosslet, Anja Victor, Sandra Koch, Maria Hoppe-Lotichius, Michael Heise, Torsten Hansen, Michael B. Pitton, Ina M. Niederle, Marcus Schuchmann, Arndt Weinmann, Christoph Düber, Peter R. Galle, Gerd Otto. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liverScandinavian Journal of Gastroenterology 2012; 47(6): 718 doi: 10.3109/00365521.2012.677952
25
Alejandro Forner, Marine Gilabert, Jordi Bruix, Jean-Luc Raoul. Treatment of intermediate-stage hepatocellular carcinomaNature Reviews Clinical Oncology 2014; 11(9): 525 doi: 10.1038/nrclinonc.2014.122
26
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
27
Xiang-yu Zhong, Xiao-xue Xu, Jian-hua Yu, Gui-xing Jiang, Yang Yu, Sheng Tai, Zhi-dong Wang, Yun-fu Cui. Clinical and biological significance of Cdk10 in hepatocellular carcinomaGene 2012; 498(1): 68 doi: 10.1016/j.gene.2012.01.022
28
Seung Min Jung, Jeong Won Jang, Chan Ran You, Sun Hong Yoo, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastasesJournal of Gastroenterology and Hepatology 2012; 27(4): 684 doi: 10.1111/j.1440-1746.2011.06917.x
29
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer 2012; 48(5): 599 doi: 10.1016/j.ejca.2011.12.021
30
V. V. Breder, K. K. Laktionov, M. I. Davydov. PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONSMedical Council 2017; (14): 11 doi: 10.21518/2079-701X-2017-14-11-23
31
Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Arunee Dechaphunkul. LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective studyBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12040-z
32
Ivonete Sandra de Souza e Silva, Adriano Miziara Gonzáles, Marcelo Moura Linhares, Alcides Salzedas Neto, Denis Szejnfeld, Giuseppe D'Ippolito, Gaspar de Jesus Lopes Filho, Valeria Pereira Lanzoni, Carla Adriana Matos. Long-term follow-up after resection of thyroid metastases from hepatocellular carcinoma in noncirrhotic liverArquivos Brasileiros de Endocrinologia & Metabologia 2013; 57(4): 327 doi: 10.1590/S0004-27302013000400009
33
Jaleh Varshosaz, Farshid Hassanzadeh, Hojjat Sadeghi, Zahra Ghelich Khan, Mahboobeh Rostami. Retinoic Acid Decorated Albumin-Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular CarcinomaJournal of Nanomaterials 2013; 2013: 1 doi: 10.1155/2013/254127
34
Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux, Jean‐Luc Raoul. Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaCancer 2012; 118(1): 147 doi: 10.1002/cncr.26255
35
Hoi-Hung Chan, Tian-Huei Chu, Hsin-Fan Chien, Cheuk-Kwan Sun, E-Ming Wang, Huay-Ben Pan, Hsiao-Mei Kuo, Tsung-Hui Hu, Kwok-Hung Lai, Jiin-Tsuey Cheng, Ming-Hong Tai. Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantationBMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-83
36
Mengchao Wu, Feng Shen, Jiamei Yang, Weiping Zhou, Yiqun Yan, Xiaohui Fu. Primary Liver Cancer2012; : 399 doi: 10.1007/978-3-642-28702-2_13